Raven Provides OMNiPOWER™ Platform for World’s First OMNi Farm Enterprise
Raven Industries, Inc. (the Company; NASDAQ:RAVN), the leader in autonomous agriculture technology, announced today the purchase of a second OMNiPOWER™ platform by Haggerty AgRobotics. Raven’s driverless ag and precision technology deliver impactful solutions for local and enterprise farms as the agriculture industry’s labor shortages continue to grow.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210615005181/en/
The second OMNiPOWER platform will allow Haggerty AgRobotics to lead the industry as one of the first customers to implement a real-world fleet of autonomous machines. Haggerty AgRobotics will now manage a fleet of OMNi platforms with machine-to-machine connectivity through the Viper® 4+ field computer. (Photo: Business Wire)
“Labor shortage concerns within our local growers have really elevated the need for more automation and robotics on the farm,” said Chuck Baresich, President of Haggerty AgRobotics.
Haggerty Creek Ltd., an establised company delivering grain and crop input needs for growers in Ontario, Canada, has been collaborating with Raven to solve industry challenges for over a decade. In 2020, Haggerty Creek Ltd. purchased its first OMNiPOWER and in 2021 purchased OMNiDRIVE to help farmers with operational challenges they face. The growing demand for driverless ag technology as an impactful solution for labor shortages pushed Baresich to launch Haggerty AgRobotics, a service focused entirely on autonomy, robotics and technology automation at the farm level.
The second OMNiPOWER platform will allow Haggerty AgRobotics to lead the industry as one of the first customers to implement a real-world fleet of autonomous machines. Baresich will now manage a fleet of OMNi platforms with machine-to-machine connectivity through the Viper® 4+ field computer. The integration of Raven’s advanced precision farming technology within the OMNiPOWER platform allows for a seamless user experience and real-time shared coverage visibility.
“As one of the first customers of this technology, we are very excited to bring Raven driverless ag solutions to the market in a big way,” said Baresich. “The recent updates and advancements to Raven’s technology are impressive and we have experienced incredible performance in our 2021 spring program. We purchased our second OMNiPOWER platform to continue to be on the leading edge of commercializing autonomous machines as an organized fleet.”
“Raven has made significant investments in our OMNi suite of driverless ag solutions,” said Ben Voss, Raven Applied Technology Director of Sales for North America and Australia. “It is exciting to see a progressive, ag-tech focused operation like Haggerty AgRobotics partner with us to showcase autonomy and precision applications in the agriculture market. OMNiPOWER and OMNiDRIVE position both of us as autonomy pioneers in the global agriculture industry.”
Raven unveiled their OMNi brand of autonomous solutions less than a month ago and is actively fulfilling orders for both OMNiPOWER and OMNiDRIVE™ units worldwide. OMNiPOWER™ is a self-propelled power platform that easily interchanges farm implements like a sprayer or spreader. This autonomous platform empowers ag professionals to perform multiple farm tasks simultaneously without a driver. Raven’s Path to Autonomy begins with precision farming products that reduce driver fatigue and graduates up to full driverless ag technology automation.
By investing in driverless ag technology, Raven continues to design solutions that reduce operating costs, decrease inputs, and improve yields for ag professionals around the world. Available to order today at RavenPrecision.com.
About Raven Industries, Inc.
Raven Industries (NASDAQ: RAVN) is dedicated to providing innovative, high-value products and solutions that solve great challenges throughout the world. Raven is a leader in precision agriculture, high-performance specialty films, and lighter-than-air technologies. Since 1956, Raven has designed, produced, and delivered exceptional solutions, earning the company a reputation for innovation, product quality, high performance, and unmatched service. For more information, visit https://ravenind.com.
About Raven Applied Technology
For decades, Raven Applied Technology has been committed to maximizing operational efficiencies through its innovative agriculture technology. The company’s autonomous product suite, Raven Autonomy™, is an extension of that core. From field computers to sprayer and planter controls, GPS guidance steering systems, logistics technology, and autonomous solutions — Raven provides precision agriculture products designed for ag retailers and growers to remain competitive and profitable into the future. Learn more at https://ravenprecision.com.
About Haggerty Creek Ltd.
Haggerty Creek Ltd. was established in 2001 to fill a market need in Ontario’s four counties area, being Lambdon, Middlesex, Elgin and Kent counties. Located north of Bothwell, Ontario, Haggerty Creek provides whole farm solutions, starting with precision crop planning and application, and ending with grain handling and marketing. In response to the growing demand for driverless ag technology, the company launched Haggerty AgRobotics, positioning themselves as a pioneer in a growing industry. Learn more at https://haggertycreek.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005181/en/
Contact information
Erin Rinehart, Marketing Manager
Raven Industries
+1 (605) 336-2750
erin.rinehart@ravenind.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom